Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 01 Jul 2025

T-cell repertoire correlates with cytokine imbalance in multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Lisa Weidner
Rodolphe Poupardin
Tobias Zrzavy
Sandra Laner-Plamberger
Georg Gratz
Tanja Eichhorn
Viktoria Weber
Paulus S. Rommer
Christof Jungbauer
Dirk Strunk

Frontiers in Immunology

doi 10.3389/fimmu.2025.1604452

134 views

Original Research

Published on 01 Jul 2025

Chronic ethanol administration exacerbates memory loss by altering N6-methyladenosine-mediated epigenetic signaling

in Multiple Sclerosis and Neuroimmunology

Yuanhang Liao
Fu Xu
Yuqing Yan
Sicheng Zhou
Na Liu
Baomin Dou
Nivetha Srinivasan
Weizheng Wang
Xiongwei Zhu
Jianghong Ye

Frontiers in Immunology

doi 10.3389/fimmu.2025.1455994

238 views

Original Research

Accepted on 30 Jun 2025

Reduced Tolerogenic Factor sCD83 in NMOSD and Relapsing MOGAD: A Potential New Therapeutic Pathway

in Multiple Sclerosis and Neuroimmunology

Ariel Rechtman
Omri Zveik
Lyne Shweiki
garrick Hoichman
Tal Friedman-korn
Livnat Brill
ADI Vaknin-Dembinsky

Frontiers in Immunology

doi 10.3389/fimmu.2025.1620069

Original Research

Published on 30 Jun 2025

Longitudinal immune profiling following autologous hematopoietic stem cell transplantation in multiple sclerosis: insights into immune reconstitution and disease modulation

in Multiple Sclerosis and Neuroimmunology

Malin Müller
Ivan Pavlovic
Anna Wiberg
Joachim Burman

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601223

288 views

Original Research

Published on 30 Jun 2025

Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Jun Yin
Nadeem O. Kaakoush
Jennifer Massey
Mark Danta

Frontiers in Immunology

doi 10.3389/fimmu.2025.1590601

396 views

Review

Published on 26 Jun 2025

Rational therapeutic targeting of myeloid cells in glioblastoma: challenges and perspectives

in Multiple Sclerosis and Neuroimmunology

Faruk Akay
Maya Saleh

Frontiers in Immunology

doi 10.3389/fimmu.2025.1472710

425 views

Original Research

Published on 26 Jun 2025

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Justyna Chojdak-Łukasiewicz
Aleksandra Kołtuniuk
Ewa Sawicka
Anna Pokryszko-Dragan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1545430

342 views

Original Research

Accepted on 20 Jun 2025

Exploring the Mycobiota in Multiple Sclerosis: Its Influence on Disease Development and Progression

in Multiple Sclerosis and Neuroimmunology

Ane Otaegui
Miriam Gorostidi Aicua
Laura Martins Almeida
Ainhoa Alberro Garitano
Leire Romarate García
Idoia Mendiburu Arrieta
Amaya Álvarez de Arcaya
Maialen Arruti Gonzalez
Tamara Castillo Triviño
David Otaegui

Frontiers in Immunology

doi 10.3389/fimmu.2025.1625794

245 views

Review

Published on 19 Jun 2025

Role of meningeal lymphatic vessels in brain homeostasis

in Multiple Sclerosis and Neuroimmunology

Meng-Ying Zhao
Chao-Yuan Ye
Yuan-Cheng Liu
Xiao-Ming Wang
Jun-Cai Fu
Xin-Yuan Liu
Rui Zhu
Yi-Zhao Li
Qing Tian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1593630

429 views

Editorial

Accepted on 18 Jun 2025

Editorial: Community Series in Trends in Neuroimmunology: cross-talk between brainresident and peripheral immune cells in both health and disease, volume II

in Multiple Sclerosis and Neuroimmunology

Suryanarayan Biswal
Janina Edith Borgonovo
Carlos Leandro Freites
Veronica Martinez Cerdeño
Rajnikant Mishra
Shashank Kumar Maurya
Estela Maris Muñoz

Frontiers in Immunology

doi 10.3389/fimmu.2025.1644278

138 views

Original Research

Published on 18 Jun 2025

The contribution of BTK signaling in myeloid cells to neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Claudia Bassani
Marta Molinari
Valentina Romeo
Vittorio Martinelli
Ursula Boschert
Gianvito Martino
Luca Muzio
Cinthia Farina

Frontiers in Immunology

doi 10.3389/fimmu.2025.1595069

641 views

Original Research

Accepted on 17 Jun 2025

Subcortical Shape Biomarkers Reveal Limbic and Basal Ganglia Damage in Anti-LGI1 Encephalitis

in Multiple Sclerosis and Neuroimmunology

Jianping Qiao
Zhishun Wang
Jiaxiang Xin
Shengjun Wang
Anning Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1623577

202 views

Mini Review

Published on 16 Jun 2025

Brain-derived blood biomarkers in multiple sclerosis—current trends and beyond

in Multiple Sclerosis and Neuroimmunology

Shamundeeswari Anandan
Karina Maciak
Regina Breinbauer
Sepideh Mostafavi
Christopher Elnan Kvistad
Oivind Torkildsen
Kjell-Morten Myhr

Frontiers in Immunology

doi 10.3389/fimmu.2025.1569503

762 views

Systematic Review

Published on 16 Jun 2025

Osteopontin as a diagnostic and NTZ-response biomarker of multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Adela González-Jiménez
Elena Urcelay
Laura Espino-Paisán

Frontiers in Immunology

doi 10.3389/fimmu.2025.1597117

451 views

Correction

Published on 13 Jun 2025

Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series

in Multiple Sclerosis and Neuroimmunology

Regina Berkovich
Jonathan Calkwood
Heidi Crayton
April Erwin
Simon Faissner
Ralf Gold
Joshua Katz
Mark Leekoff

Frontiers in Immunology

doi 10.3389/fimmu.2025.1609054

474 views

Review

Published on 10 Jun 2025

Multiple sclerosis: etiology in the context of neurovascular unit and immune system involvement and advancements with in vitro blood–brain barrier models

in Multiple Sclerosis and Neuroimmunology

Aya A. El-Taibany
Parichehr Heydarian
Daniel A. Porada
Michael C. Seeds
Anthony Atala

Frontiers in Immunology

doi 10.3389/fimmu.2025.1595276

1,324 views